Ethan Settembre, PhD

Cambridge, Massachusetts, United States
Ethan Settembre, Ph.D. is the VP of R&D for Seqirus, one of the world’s largest influenza vaccine producers. At Seqirus, Ethan leads the R&D team responsible for developing vaccines that offer the greatest protection possible against infectious diseases, with a specific focus on influenza, by both improving current approaches and pursuing new vaccine technologies. These new innovations include approaches to RNA vaccines, cell-based manufacturing methods, adjuvants, and protein-based antigens.

Ethan received post-doctoral training in Structural Vaccinology at Harvard Medical School, where he helped elucidate the structure of key viral proteins at the atomic level. Previously, Ethan worked at Novartis Vaccines and Diagnostics where he led projects in multiple disease areas (e.g. RSV, Influenza, Parvovirus B19, etc.).
Speaking In
2:15 PM - 3:15 PM (PDT)
Monday, June 13
While COVID-19 only first emerged in 2019, influenza has been plaguing humanity for centuries…